Cyclic bleeding disorders: Difference between revisions
Feedback

From WikiLectures

mNo edit summary
(checked by the editor)
 
(33 intermediate revisions by one other user not shown)
Line 1: Line 1:
__toc__
__toc__


[[Menstrual cycle|Cyclic bleeding]] disorders are a common problem and the cause of about '''15-20 % visits''' to gynecological clinics. It is mostly a manifestation of the female genitals illness or hormonal disorders, rarely a manifestation of general illness. The most important diagnostic criterium is carefully managed '''menstrual calendar'''.
[[Menstrual cycle|Cyclic bleeding]] disorders are a common problem and the cause of about '''15-20 % visits''' to gynecological clinics. It is mostly a manifestation of the female genitals illness or hormonal disorders, rarely a manifestation of general illness. The most important diagnostic criterium is carefully managed '''menstrual calendar'''.  


Division according to symptoms:  
Division according to symptoms:  
Line 22: Line 22:
The diagnostic criterium for division is '''progesterone test'''. If menstrual bleeding occurs within 14 days after the application of progesterone, it is about '''amenorrhea I. grade''' (sufficient endometrial proliferation), if it doesn't show up, it is '''amenorrhea II. grade''' (with insufficient endometrial proliferation). It is always needed to '''disprove pregnancy''' and any other '''organic cause''' (e.g. ''kryptomenorrhea'' – cyclical changes on the endometrium are under way, but blood is not secreted due to mechanical obstruction).  
The diagnostic criterium for division is '''progesterone test'''. If menstrual bleeding occurs within 14 days after the application of progesterone, it is about '''amenorrhea I. grade''' (sufficient endometrial proliferation), if it doesn't show up, it is '''amenorrhea II. grade''' (with insufficient endometrial proliferation). It is always needed to '''disprove pregnancy''' and any other '''organic cause''' (e.g. ''kryptomenorrhea'' – cyclical changes on the endometrium are under way, but blood is not secreted due to mechanical obstruction).  


{{Podrobnosti|Amenorrhoea}}
{{Details|Amenorrhoea}}


==Disorders of cycle onset and termination==
==Disorders of cycle onset and termination==
Line 83: Line 83:
It most often occurs during '''anovulation''', irregular [[ovulation]] or during the extension of the follicular phase. Less often, it is caused by the persistence of the [[Corpus Luteum|corpus luteum]]. The cause are '''hormonal disorders''' ([[polycystic ovary syndrome]], [[prolactinoma]]), '''lifestyle disorders''' (increased stress, drastic diets, extreme sports, [[eating disorders]]), as well as '''inflammation''', '''cysts''', '''polyps''' a '''tumors''' in the female reproductive system.  
It most often occurs during '''anovulation''', irregular [[ovulation]] or during the extension of the follicular phase. Less often, it is caused by the persistence of the [[Corpus Luteum|corpus luteum]]. The cause are '''hormonal disorders''' ([[polycystic ovary syndrome]], [[prolactinoma]]), '''lifestyle disorders''' (increased stress, drastic diets, extreme sports, [[eating disorders]]), as well as '''inflammation''', '''cysts''', '''polyps''' a '''tumors''' in the female reproductive system.  


During the '''medical therapy''' , we apply '''[[progesteron]]e in the second half of the cycle.'''. At the same time, it can be combined with preparations containing  '''[[estrogene]]s''' ([[Hormonal contraception|combined hormonal contraception]]). Anovulaci u žen, které se snaží o těhotenství lze stimulovat podáním clomifen citrátu a [[FSH]].  
During the '''medical therapy''' , we apply '''[[Gestagens|progesterone]] in the second half of the cycle.''' At the same time, it can be combined with preparations containing  '''[[Estrogens|estrogenes]]''' ([[Hormonal contraception|combined hormonal contraception]]). Anovulation in women who are trying to conceive, can be stimulated by administration of clomiphene citrate and [[FSH]].  


===Polymenorea===
===Polymenorrhea===
'''Příliš častá''' menstruace (cyklus trvá '''méně než 22 dní''').<ref name="Gynekologie">{{Citace
'''Too frequent''' menstruation (cyclus lasts ''''less than 22 days''').<ref name="Gynecology">{{Cite
| typ = kniha
| type = book
| příjmení1 = Hájek
| surname1 = Hájek
| jméno1 = Zdeněk
| name1 = Zdeněk
| příjmení2 = Čech
| surname2 = Čech
| jméno2 = Evžen
| name2 = Evžen
| příjmení3 = Maršál
| surname3 = Maršál
| jméno3 = Karel
| name3 = Karel
| kolektiv = ano
| others = yes
| titul = Porodnictví
| title = Porodnictví
| vydání = 3
| edition = 3
| místo = Praha
| location = Praha
| vydavatel = Grada
| publisher = Grada
| rok = 2014
| year = 2014
| rozsah = 538
| range = 538
| isbn = 978-80-247-4529-9
| isbn = 978-80-247-4529-9
}}</ref>
}}</ref>
Obvykle dochází ke zkracování luteální fáze, což způsobí '''předčasný zánik folikulu''' doprovázený poklesem hladin estrogenů. Anovulační cykly může způsobit i '''nadměrný stres''' a '''zvýšená psychická či fyzická zátěž'''. Zkrácení folikulární fáze je méně časté a může být následováno ovulací (v takovém případě není potřeba terapie). Příliš časté krvácení může u pacientek způsobit '''[[anémie|anémii]]'''. Z toho důvodu je vhodné doplnit diagnostiku i o vyšetření krevních hodnot a hladin železa.  
There is usually a shortening of the luteal phase, which causes '''premature death of the follicle''' accompanied by a drop in estrogen levels. Anovulatory cycles can also be caused by '''excessive stress''' and '''increased mental or physical stress'''. Shortening of the follicular phase is less common and may be followed by ovulation (in that case, no therapy is needed). Excessive bleeding can cause '''[[anemia|anemia]]'''. For this reason, it is appropriate to supplement the diagnosis with the examination of blood values ​​and iron levels.  


Terapie obvykle spočívá v podávání '''kombinované hormonální antikoncepce'''. Pokud je příčinou zkrácená luteální fáze, lze podávat progesteron v druhé fázi cyklu. Anovulaci u žen, které se snaží o těhotenství stimulujeme podáním clomifen citrátu a [[FSH]]. V případě manifestní anémie, indikujeme '''suplementaci železa'''.
Therapy is usually based on administration of '''combined hormonal contraception'''. If the cause is a shortened luteal phase, progesterone can be given in the second phase of the cycle. We stimulate anovulation in women who are trying to conceive by administering clomiphene citrate and [[FSH]]. In case of manifestation of anemia, we indicate '''iron supplementation'''.


==Poruchy intenzity a délky menstruačního krvácení==
==Disorders of the intensity and duration of menstrual bleeding==
Menstruační krvácení obvykle trvá '''3-5 dnů''' a celková výše krevní ztráty by neměla převýšit 1 ml krve na 1 kg hmotnosti ženy (obvykle '''35-80 ml'''). V klinické praxi se krevní ztráta měří podle počtu použitých vložek za den (obvykle 2-7). Přesnější hodnoty krevní ztráty získáme zvážením použitých vložek.<ref name="Gynekologie">{{Citace
Menstrual bleeding usually lasts for '''3-5 days''' and the total amount of blood loss should not exceed 1 ml of blood per 1 kg of the woman's weight (usually '''35-80 ml'''). In clinical practice, blood loss is measured by the number of pads used per day (usually 2-7). More accurate values ​​of blood loss can we get by considering the pads used.<ref name="Gynecology">{{Cite
| typ = kniha
| type = book
| příjmení1 = Hájek
| surname1 = Hájek
| jméno1 = Zdeněk
| name1 = Zdeněk
| příjmení2 = Čech
| surname2 = Čech
| jméno2 = Evžen
| name2 = Evžen
| příjmení3 = Maršál
| surname3 = Maršál
| jméno3 = Karel
| name3 = Karel
| kolektiv = ano
| others = yes
| titul = Porodnictví
| title = Porodnictví
| vydání = 3
| edition = 3
| místo = Praha
| location = Praha
| vydavatel = Grada
| publisher = Grada
| rok = 2014
| year = 2014
| rozsah = 538
| range = 538
| isbn = 978-80-247-4529-9
| isbn = 978-80-247-4529-9
}}</ref>
}}</ref>


===Hypermenorea a menoragie===
===Hypermenorrhea and menorrhagia===
''Hypermenorea'' je definována jako '''nadměrně silné krvácení''' (více než 5 vložek za den), které bývá obvykle doprovázeno ''menoragií'', což je '''prodloužené krvácení''' (déle než 7 dní).  
''Hypermenorrhea'' is defined as '''excessive bleeding''' (more than 5 pads per day), which is usually accompanied by ''menorrhagia'', which is '''prolonged bleeding''' (more than 7 days).  


Příčiny zahrnují organické poruchy – '''změny na endometriu''' (polypy, chronická endometritida, nepravidelné odlučování děložní sliznice) a '''změny na myometriu''' (myomy, funkční nedostatečnost svaloviny po děložní hypoplázii, adenomyóza), '''nádorová onemocnění''', dále '''funkční poruchy''' (lokální fibrinolýza) a extragenitální poruchy zahrnující '''systémová onemocnění''' ([[hypertenze]], choroby ledvin, [[Hemoragické diatézy (patologie)|hemoragické diatézy]], [[Kurděje|avitaminóza C]] a B) a '''antikoagulační terapii'''.
Causes include organic disorders – '''endometrial changes''' (polyps, chronic endometritis, irregular endometrial shedding) and '''myometrium changes''' (myoma, functional muscle insufficiency after uterine hypoplasia, adenomyosis), '''cancer illnesses''', further '''functional disorders''' local fibrinolysis) and extragenital disorders including '''systemic diseases''' ([[hypertension]], kidney diseases, [[hemorrhagic diatheses]], [[Scurvy|avitaminosis C]] and B) and '''anticoagulans therapy'''.


Pro '''diagnostiku''' je zásadní vyloučit či potvrdit organickou příčinu (především nádorová onemocnění). Používáme UZ vyšetření, stanovení hladin hormonů, případně hysteroskopii, separovanou abrazi hrdla a těla děložního a histologické vyšetření.   
For '''diagnosis''', it is essential to rule out or confirm an organic cause (mainly cancer). We use ultrasound examination, determination of hormone levels, possibly hysteroscopy, separate abrasion of the throat and body of the uterus and histological examination.   


'''Léčba''' je závislá na konkrétní diagnóze. Systémové poruchy řešíme ve spolupráci s internistou, hematologem a endokrinologem.
'''Treatment''' depends on the concrete diagnosis. We deal with systemic disorders in cooperation with an internist, a hematologist and an endocrinologist.
Pro regulaci krvácení podáváme '''progesteron v druhé polovině cyklu''', případně '''kombinovanou HA'''. V perimenopauzálním období zvažujeme '''hormonální substituci'''. Pro zastavení krvácení aplikujeme '''antifibrinolytika''' (především u mladých) nebo '''hemostatika''' (kyselina paraaminobenzoová, kyselina tranexamová). Redukci krevních ztrát umožní podání '''nesteroidních antiflogistik''' (hlavně COX-2). V případě organických příčin, které nereagují na konzervativní léčbu, indikujeme '''operační metody''' (hysteroskopické a laparoskopické výkony, hysterektomie).
To regulate bleeding, we administer '''progesterone in the second half of the cycle''' or combined '''HA'''. In the perimenopausal period, we consider '''hormone replacement.''' To stop bleeding, we apply '''antifibrinolytics''' (especially by young people) or '''hemostatics''' (paraaminobenzoic acid, tranexamic acid). Administration of '''non-steroidal anti-inflammatory drugs''' (mainly COX-2) will reduce blood loss. In the case of organic causes that do not respond to conservative treatment, we indicate '''surgical methods''' (hysteroscopic and laparoscopic procedures, hysterectomy).


===Hypomenorea===
===Hypomenorrhea===
'''Slabé cyklické krvácení''' (méně než 2 vložky denně). Bývá způsobeno odlišnou strukturou a cévním zásobením endometria.  
'''Week cyclical bleeding''' (less than 2 pads per day). It is caused by the different structure and vascular supply of the endometrium.  


Příčinou může být  '''nedostatečná funkce ovaria''' nebo '''alterace děložní sliznice''' (rezistence k estrogenům, fibrotizace, destrukce). Častou příčinou zániku bazální vrstvy endometria jsou rozsáhlé '''záněty''' děložní sliznice, případně '''instrumentální revize''' děložní dutiny. Stav, kdy je děložní dutina obliterována nazýváme jako '''[[Ashermanův syndrom]]'''. V případě úplné obliterace je přítomna amenorea, pokud jsou stále zachovány některé ostrůvky endometria, projevuje se hypomenoreou.  
The reason may be '''insufficient ovarian function''' or '''alteration of the endometrium''' (estrogen resistance, fibrotization, destruction). A frequent cause of the disappearance of the basal layer of the endometrium is extensive '''inflammation''' of the endometrium, or '''instrumental revision''' of the uterine cavity. The condition when the uterine cavity is obliterated is called [[Asherman's syndrome|'''Asherman's syndrome''']]. In the case of complete obliteration, amenorrhea is present, if some islands of the endometrium are still preserved, it manifests as hypomenorrhea.  


V diagnostice stanovujeme hormonální hladiny, provádíme detekci ovulace, vyšetření ultrazvukem, hysterosalpingografii, a hysteroskopii.  
In diagnostics, we determine hormone levels, perform ovulation detection, ultrasound examination, hysterosalpingography, and hysteroscopy.  


Proliferaci endometria lze podpořit podáváním '''estrogenů'''. Sekreční transformaci stimulujeme '''gestageny'''. Při Ashermanově syndromu indikujeme hysteroskopii s '''uvolněním adhezí''' a zavedením '''nitroděložního tělíska s estrogeny''' (obvykle 1-2 měsíce).  
Endometrial proliferation can be promoted by the administration of '''estrogens'''. Secretory transformation is stimulated by '''gestagens'''. In Asherman's syndrome, we indicate hysteroscopy with '''release of adhesions''' and introduction of an '''intrauterine device with estrogens''' (usually 1-2 months).  
{{Poznámka|V případě hypomenorei s přítomným ovulačním cyklem a plně vyvinutou sekreční fází, není potřeba indikovat terapii.}}
{{Note|In the case of hypomenorrhea with a present ovulatory cycle and a fully developed secretory phase, there is no need to indicate therapy.}}


==Přídatná krvácení (mimo cyklus)==
==Additional bleeding (outside the cycle)==
Obvykle slabá krvácení (charakteru špinění), která se vyskytují mimo cyklické krvácení.
Usually light bleeding (of a spotting nature) that occurs outside of cyclical bleeding.


;Ovulační krvácení
;Ovulation bleeding
:Vyskytuje se asi u 5 % žen ve fertilním věku. Může být doprovázeno dalšími symptomy jako je bolest v podbřišku či zvýšená poševní sekrece. Krvácení způsobuje reakce endometria na pokles hladin estrogenů.
:It occurs by 5% of women in fertile age. It can be accompanied by other symptoms such as pain in the lower abdomen or increased vaginal secretion. Bleeding is caused by the endometrium's response to a drop in estrogen levels.


;Premenstruační krvácení
;Premenstrual bleeding
:Vyskytuje se několik dní před začátkem menstruace, příčinou bývá insuficience žlutého tělíska, polyp, zánět, myom, děložní hypoplazie nebo nitroděložní tělísko.  
:It occurs a few days before the start of menstruation, the cause is insufficiency of the corpus luteum, polyp, inflammation, fibroid, uterine hypoplasia or intrauterine device.


;Postmenstruační krvácení
;Postmenstrual bleeding
:Navazuje na menstruační a vzniká například v důsledku nedostatečné regenerace endometria, při nedostatku estrogenů, děložní hypoplazii, myomatóze, zánětu nebo přítomnosti nitroděložního tělíska.
:It follows the menstrual cycle and arises, for example, as a result of insufficient endometrial regeneration, estrogen deficiency, uterine hypoplasia, myomatosis, inflammation or the presence of an intrauterine device.


==Funkční poruchy==
==Functional disorders==
===Metroragie===
===Metrorrhagia===
Acyklické nepravidelné děložní krvácení různé intenzity. Nejčastěji se objevuje po menarche (juvenilní metroragie) a před menopauzou. Může být příznakem vážných patologií (endokrinopatie, záněty, nádory), z toho důvodu je podstatná pečlivá diagnostika.  
Acyclic irregular uterine bleeding of various intensity. It most often appears after menarche (juvenile metrorrhagia) and before menopause. It can be a symptom of serious pathologies (endocrinopathy, inflammation, tumors), which is why precise diagnosis is essential.  


{{Podrobnosti|Metroragie}}
{{Details|Metrorrhagia}}


===Nerovnoměrné odlučování endometria===
===Uneven shedding of the endometrium===
Abnormální '''krvácení z anatomicky normální dělohy'''. Dochází k hyperproliferaci endometria, která není oponována gestageny při anovulačích cyklech. Nadměrná stimulace děložní sliznice estrogeny (dlouhodobá, vysoké hladiny) vede k jejímu nadměrnému růstu, které způsobí sníženou trofiku a sliznice se tak stane '''křehká'''. Při kolísání hladin estrogenu se začne nerovnoměrně odlučovat. Krvácení bývá silné a prodloužené.
Abnormal bleeding from an anatomically normal uterus. Endometrial hyperproliferation occurs, which is not opposed by progestogens during anovulatory cycles. Excessive stimulation of the endometrium by estrogens (long-term, high levels) leads to its excessive growth, which causes reduced trophicity and thus the mucosa becomes '''fragile'''. When estrogen levels fluctuate, it begins to be secreted unevenly. Bleeding tends to be heavy and prolonged.


Terapie spočívá v '''zástavě krvácení a prevenci recidiv'''. Zástavu provedeme '''norsteroidy''' (syntetické progestiny s estrogenním účinkem), rovněž lze použít i.m. aplikaci estrogenů a progesteronu. V případě vzniklé anémie zahajujeme její terapii. Dysfunkci napravujeme podáním estrogenů (podpora pevnosti a trofiky endometria) a gestagenů k navození transformace endometria. V prevenci recidiv indikujeme '''cyklickou aplikaci progesteronu''' v druhé polovině cyklu, kombinovanou HA, případně hormonální substituci.
Therapy consists of '''stopping bleeding''' and '''preventing recurrences'''. We stop bleeding by using '''norsteroids''' (synthetic progestins with an estrogenic effect), i.m. application of estrogens and progesterone can also be used. In case of anemia, we start its medical treatment. We correct the dysfunction by administering estrogens (supporting the strength and trophicity of the endometrium) and gestagens to induce the transformation of the endometrium. In the prevention of '''relapses''', we indicate the cyclic application of progesterone in the second half of the cycle, combined HA, or hormone replacement.


==Patologické doprovodné symptomy==
==Pathological accompanying symptoms==
===Dysmenorea===
===Dysmenorrhea===
Charakterizována jako '''bolest''' a další '''somatické příznaky''' (průjem, bolesti hlavy, nauzea, zvracení, kolaps), které začínají těsně před menstruačním krvácení a mizí po následujících 2-3 dnech. Rozlišujeme '''primární''' (idiopatickou) a '''sekundární''' (podmíněna patologickými procesy) dysmenoreu.
Characteristic is '''pain''' and other '''somatic symptoms''' (diarrhea, headaches, nausea, vomiting, collapse) that begin just before menstrual bleeding and disappear after the following 2-3 days. We distinguish between '''primary''' (idiopathic) and '''secondary''' (due to pathological processes) dysmenorrhea


{{Podrobnosti|Dysmenorrhoea}}
{{Details|Dysmenorrhoea}}


===Premenstruační syndrom===
===Premenstrual syndrome===
'''Pravidelná''' přítomnost '''somatických a psychických obtíží v luteální fázi''' menstruačního cyklu. Bývají různého charakteru a intenzity. Vyskytuje se u vysokého počtu žen. Nejčastěji se objevuje 7 dní před menses a s jeho nástupem odeznívají. Příčinou je pravděpodobně dysbalance endokrinního a neurotransmiterového systému, které mají vazbu na psychické faktory. Zvláštním typem je '''premenstruační dysforická porucha''', při které jsou příznaky PMS natolik akcelerované, že znemožňují sociální adaptaci pacientky (afektivní labilita, úzkosti, tenze, dysforie apod.).  
'''Regular''' presence of '''somatic and psychological problems''' in the luteal phase of the menstrual cycle. They are of different nature and intensity. It occurs in a high number of women. It most often appears 7 days before menses and disappears with its onset. The cause is probably an imbalance of the endocrine and neurotransmitter systems, which are linked to psychological factors. A special type is '''premenstrual dysphoric disorder''', in which the symptoms of PMS are so accelerated that they make the patient's social adaptation impossible (affective lability, anxiety, tension, dysphoria, etc.).  


Pro stanovení diagnózy je nutná přítomnost jednoho somatického a jednoho psychického příznaku ve třech po sobě jdoucích cyklech.  
To establis the diagnosis, it requires the presence of one somatic and one psychological symptom in three consecutive cycles.  
Léčba je symptomatická. Základ tvoří '''úprava životního stylu''' a '''psychiatrická péče'''. Z léku indikujeme '''hormonální antikoncepci''' s nízkým obsahem estrogenů v kombinaci s drospirenonem (gestagen s antimineralokortikoidní aktivitou), která snižuje tvorbu edémů. Při léčbě bolestí indikujeme '''nesteroidní antiflogistika'''. Někdy podáváme suplementaci vitamínů (B<sub>6</sub>, E) a minerálů (magnezium, kalcium).
Léčba je symptomatická. '''Lifestyle modification''' and '''psychiatric care''' are the basis.Of the drug, we indicate '''hormonal contraception''' with a low estrogen content in combination with drospirenone (gestagen with antimineralocorticoid activity), which reduces the formation of edema. In the treatment of the pain, we indicate '''non-steroidal antiphlogistics'''. Sometimes we give supplementation of vitamins (B6, E) and minerals (magnesium, calcium).


{{Podrobnosti|Premenstruální syndrom}}
{{details|Premenstrual syndrome}}
<noinclude>
<noinclude>


== Source ==
== Source ==
=== Související články ===
=== Related articles ===
* [[Dysmenorrhoea]]
* [[Dysmenorrhoea]]
* [[Premenstruální syndrom]]
* [[Premenstrual syndrome]]
* [[Menstruační cyklus]]
* [[Menstrual cycle]]
* [[Metroragie]]
* [[Metrorrhagia]]


=== Zdroj ===
=== Source ===
* {{Citace
* {{Cite
|typ = web
|type = web
|korporace =  
|corporation =  
|příjmení1 = Beneš
|surname1 = Beneš
|jméno1 = Jiří
|name1 = Jiří
|příjmení2 =
|surname2 =
|jméno2 =  
|name2 =  
|příjmení3 =
|surname3 =
|jméno3 =  
|name3 =  
|kolektiv =
|others =
|název = Studijní materiály
|source_name = Studijní materiály
|rok = 2009
|year = 2009
|datum_revize =  
|date_of_revision =  
|citováno = 2010
|cited = 2010
|url = http://jirben.wz.cz
|url = http://jirben.wz.cz
}}
}}
* {{Citace
* {{Cite
| typ = kniha
| type = book
| příjmení1 = Hájek
| surname1 = Hájek
| jméno1 = Zdeněk
| name1 = Zdeněk
| příjmení2 = Čech
| surname2 = Čech
| jméno2 = Evžen
| name2 = Evžen
| příjmení3 = Maršál
| surname3 = Maršál
| jméno3 = Karel
| name3 = Karel
| kolektiv = ano
| others = yes
| titul = Porodnictví
| title = Porodnictví
| vydání = 3
| edition = 3
| místo = Praha
| location = Praha
| vydavatel = Grada
| publisher = Grada
| rok = 2014
| year = 2014
| rozsah = 538
| range = 538
| isbn = 978-80-247-4529-9
| isbn = 978-80-247-4529-9
}}
}}
* {{Citace
* {{Cite
| typ = kniha
| type = book
| příjmení1 = Rob
| surname1 = Rob
| jméno1 = Lukáš
| name1 = Lukáš
| příjmení2 = Martan
| surname2 = Martan
| jméno2 = Alois
| name2 = Alois
| příjmení3 = Ventruba
| surname3 = Ventruba
| jméno3 = Pavel
| name3 = Pavel
| kolektiv = ano
| others = yes
| titul = Gynekologie
| title = Gynekologie
| vydání = 3
| edition = 3
| místo = Praha
| location = Praha
| vydavatel = Grada
| publisher = Grada
| rok = 2019
| year = 2019
| rozsah = 356
| range = 356
| isbn = 978-80-7492-426-2
| isbn = 978-80-7492-426-2
}}
}}
Line 246: Line 246:
</noinclude>
</noinclude>


[[Kategorie:Gynekologie]]
[[Category:Gynecology]]

Latest revision as of 17:16, 31 January 2023

Cyclic bleeding disorders are a common problem and the cause of about 15-20 % visits to gynecological clinics. It is mostly a manifestation of the female genitals illness or hormonal disorders, rarely a manifestation of general illness. The most important diagnostic criterium is carefully managed menstrual calendar.

Division according to symptoms:

  • amenorrhea (primary, secondary),
  • disorders of cycle onset and termination (early/late menarche and menopause),
  • menstrual rhythm disorder (oligomenorrhea, polymenorrhea),
  • disorder of intensity and duration of bleeding (hypermenorrhea, hypomenorrhea, menorrhagia),
  • additional bleeding (out of cycle),
  • functional disorders of the cycle (metrorrhagia, uneven shedding of the endometrium),
  • pathological accompanying symptoms (dysmenorrhea, premenstrual syndrome).

According to pathophysiology, we distinguish disorders at the level of the hypothalamus, pituitary gland or ovaries.

Menstrual cycle

Amenorrhea[edit | edit source]

A condition where there is no menstrual bleeding. We divide it to:

  • primary – if the girl experiences no bleeding until the age of 15 (congenital developmental defects, endocrine disorders, virilization),
  • secondary – absence of menstruation for more than 3 months by women who have already menstruated (central and ovarian causes, endocrinopathy, internal diseases, operations, inflammations, tumors, polyps on the genital system).


The diagnostic criterium for division is progesterone test. If menstrual bleeding occurs within 14 days after the application of progesterone, it is about amenorrhea I. grade (sufficient endometrial proliferation), if it doesn't show up, it is amenorrhea II. grade (with insufficient endometrial proliferation). It is always needed to disprove pregnancy and any other organic cause (e.g. kryptomenorrhea – cyclical changes on the endometrium are under way, but blood is not secreted due to mechanical obstruction).

Searchtool right.svg For more information see Amenorrhoea.

Disorders of cycle onset and termination[edit | edit source]

Physiological beginning of menstruatione (menarche) is usually between 10-15 a year, if it starts earlier, we refer to it as menarche praecox, in case of late arrival menarche tarda. End of menstruation (menopause) occurs physiologically between 49-51. a year. We refer to deviations as premature or late menopause.

Follicular phase disorders caused by GnSAF dysfunction

Disorders of the menstrual rhythm[edit | edit source]

The physiological menstrual cycle lasts in an interval of 28±3 days[1]. The regularity of cyclical bleeding begins within 2 years from menarche,[1] we consider the disorders to be (to a certain extent) physiological. We consider disorders arising after this time as pathologies. We diagnose using a hormonal examination and ultrasound per vaginam (specifies the length of the follicular and luteal phase, or anovulation).

Oligomenorrhea[edit | edit source]

Lengthening the interval between menstrual bleeding (longer than 35 days).[1] Bleeding is usually prolonged and more intense. It most often occurs during anovulation, irregular ovulation or during the extension of the follicular phase. Less often, it is caused by the persistence of the corpus luteum. The cause are hormonal disorders (polycystic ovary syndrome, prolactinoma), lifestyle disorders (increased stress, drastic diets, extreme sports, eating disorders), as well as inflammation, cysts, polyps a tumors in the female reproductive system.

During the medical therapy , we apply progesterone in the second half of the cycle. At the same time, it can be combined with preparations containing estrogenes (combined hormonal contraception). Anovulation in women who are trying to conceive, can be stimulated by administration of clomiphene citrate and FSH.

Polymenorrhea[edit | edit source]

Too frequent menstruation (cyclus lasts 'less than 22 days).[1] There is usually a shortening of the luteal phase, which causes premature death of the follicle accompanied by a drop in estrogen levels. Anovulatory cycles can also be caused by excessive stress and increased mental or physical stress. Shortening of the follicular phase is less common and may be followed by ovulation (in that case, no therapy is needed). Excessive bleeding can cause anemia. For this reason, it is appropriate to supplement the diagnosis with the examination of blood values ​​and iron levels.

Therapy is usually based on administration of combined hormonal contraception. If the cause is a shortened luteal phase, progesterone can be given in the second phase of the cycle. We stimulate anovulation in women who are trying to conceive by administering clomiphene citrate and FSH. In case of manifestation of anemia, we indicate iron supplementation.

Disorders of the intensity and duration of menstrual bleeding[edit | edit source]

Menstrual bleeding usually lasts for 3-5 days and the total amount of blood loss should not exceed 1 ml of blood per 1 kg of the woman's weight (usually 35-80 ml). In clinical practice, blood loss is measured by the number of pads used per day (usually 2-7). More accurate values ​​of blood loss can we get by considering the pads used.[1]

Hypermenorrhea and menorrhagia[edit | edit source]

Hypermenorrhea is defined as excessive bleeding (more than 5 pads per day), which is usually accompanied by menorrhagia, which is prolonged bleeding (more than 7 days).

Causes include organic disorders – endometrial changes (polyps, chronic endometritis, irregular endometrial shedding) and myometrium changes (myoma, functional muscle insufficiency after uterine hypoplasia, adenomyosis), cancer illnesses, further functional disorders local fibrinolysis) and extragenital disorders including systemic diseases (hypertension, kidney diseases, hemorrhagic diatheses, avitaminosis C and B) and anticoagulans therapy.

For diagnosis, it is essential to rule out or confirm an organic cause (mainly cancer). We use ultrasound examination, determination of hormone levels, possibly hysteroscopy, separate abrasion of the throat and body of the uterus and histological examination.

Treatment depends on the concrete diagnosis. We deal with systemic disorders in cooperation with an internist, a hematologist and an endocrinologist. To regulate bleeding, we administer progesterone in the second half of the cycle or combined HA. In the perimenopausal period, we consider hormone replacement. To stop bleeding, we apply antifibrinolytics (especially by young people) or hemostatics (paraaminobenzoic acid, tranexamic acid). Administration of non-steroidal anti-inflammatory drugs (mainly COX-2) will reduce blood loss. In the case of organic causes that do not respond to conservative treatment, we indicate surgical methods (hysteroscopic and laparoscopic procedures, hysterectomy).

Hypomenorrhea[edit | edit source]

Week cyclical bleeding (less than 2 pads per day). It is caused by the different structure and vascular supply of the endometrium.

The reason may be insufficient ovarian function or alteration of the endometrium (estrogen resistance, fibrotization, destruction). A frequent cause of the disappearance of the basal layer of the endometrium is extensive inflammation of the endometrium, or instrumental revision of the uterine cavity. The condition when the uterine cavity is obliterated is called Asherman's syndrome. In the case of complete obliteration, amenorrhea is present, if some islands of the endometrium are still preserved, it manifests as hypomenorrhea.

In diagnostics, we determine hormone levels, perform ovulation detection, ultrasound examination, hysterosalpingography, and hysteroscopy.

Endometrial proliferation can be promoted by the administration of estrogens. Secretory transformation is stimulated by gestagens. In Asherman's syndrome, we indicate hysteroscopy with release of adhesions and introduction of an intrauterine device with estrogens (usually 1-2 months).

In the case of hypomenorrhea with a present ovulatory cycle and a fully developed secretory phase, there is no need to indicate therapy.

Additional bleeding (outside the cycle)[edit | edit source]

Usually light bleeding (of a spotting nature) that occurs outside of cyclical bleeding.

Ovulation bleeding
It occurs by 5% of women in fertile age. It can be accompanied by other symptoms such as pain in the lower abdomen or increased vaginal secretion. Bleeding is caused by the endometrium's response to a drop in estrogen levels.
Premenstrual bleeding
It occurs a few days before the start of menstruation, the cause is insufficiency of the corpus luteum, polyp, inflammation, fibroid, uterine hypoplasia or intrauterine device.
Postmenstrual bleeding
It follows the menstrual cycle and arises, for example, as a result of insufficient endometrial regeneration, estrogen deficiency, uterine hypoplasia, myomatosis, inflammation or the presence of an intrauterine device.

Functional disorders[edit | edit source]

Metrorrhagia[edit | edit source]

Acyclic irregular uterine bleeding of various intensity. It most often appears after menarche (juvenile metrorrhagia) and before menopause. It can be a symptom of serious pathologies (endocrinopathy, inflammation, tumors), which is why precise diagnosis is essential.

Searchtool right.svg For more information see Metrorrhagia.

Uneven shedding of the endometrium[edit | edit source]

Abnormal bleeding from an anatomically normal uterus. Endometrial hyperproliferation occurs, which is not opposed by progestogens during anovulatory cycles. Excessive stimulation of the endometrium by estrogens (long-term, high levels) leads to its excessive growth, which causes reduced trophicity and thus the mucosa becomes fragile. When estrogen levels fluctuate, it begins to be secreted unevenly. Bleeding tends to be heavy and prolonged.

Therapy consists of stopping bleeding and preventing recurrences. We stop bleeding by using norsteroids (synthetic progestins with an estrogenic effect), i.m. application of estrogens and progesterone can also be used. In case of anemia, we start its medical treatment. We correct the dysfunction by administering estrogens (supporting the strength and trophicity of the endometrium) and gestagens to induce the transformation of the endometrium. In the prevention of relapses, we indicate the cyclic application of progesterone in the second half of the cycle, combined HA, or hormone replacement.

Pathological accompanying symptoms[edit | edit source]

Dysmenorrhea[edit | edit source]

Characteristic is pain and other somatic symptoms (diarrhea, headaches, nausea, vomiting, collapse) that begin just before menstrual bleeding and disappear after the following 2-3 days. We distinguish between primary (idiopathic) and secondary (due to pathological processes) dysmenorrhea

Searchtool right.svg For more information see Dysmenorrhoea.

Premenstrual syndrome[edit | edit source]

Regular presence of somatic and psychological problems in the luteal phase of the menstrual cycle. They are of different nature and intensity. It occurs in a high number of women. It most often appears 7 days before menses and disappears with its onset. The cause is probably an imbalance of the endocrine and neurotransmitter systems, which are linked to psychological factors. A special type is premenstrual dysphoric disorder, in which the symptoms of PMS are so accelerated that they make the patient's social adaptation impossible (affective lability, anxiety, tension, dysphoria, etc.).

To establis the diagnosis, it requires the presence of one somatic and one psychological symptom in three consecutive cycles. Léčba je symptomatická. Lifestyle modification and psychiatric care are the basis.Of the drug, we indicate hormonal contraception with a low estrogen content in combination with drospirenone (gestagen with antimineralocorticoid activity), which reduces the formation of edema. In the treatment of the pain, we indicate non-steroidal antiphlogistics. Sometimes we give supplementation of vitamins (B6, E) and minerals (magnesium, calcium).

Searchtool right.svg For more information see Premenstrual syndrome.


Source[edit | edit source]

Related articles[edit | edit source]

Source[edit | edit source]

  • BENEŠ, Jiří. Studijní materiály [online]. ©2009. [cit. 2010]. <http://jirben.wz.cz>.
  • HÁJEK, Zdeněk – ČECH, Evžen – MARŠÁL, Karel, et al. Porodnictví. 3. edition. Praha : Grada, 2014. 538 pp. ISBN 978-80-247-4529-9.
  • ROB, Lukáš – MARTAN, Alois – VENTRUBA, Pavel, et al. Gynekologie. 3. edition. Praha : Grada, 2019. 356 pp. ISBN 978-80-7492-426-2.

Reference[edit | edit source]

  1. Jump up to: a b c d e HÁJEK, Zdeněk – ČECH, Evžen – MARŠÁL, Karel, et al. Porodnictví. 3. edition. Praha : Grada, 2014. 538 pp. ISBN 978-80-247-4529-9.